DHX15 and hepatocellular carcinoma: Therefore, and considering the urgent need of accurate biomarkers for HCC in the clinical laboratory, we guaranteed further prospective validation studies to confirm the diagnostic utility of DHX15 as a noninvasive biomarker for HCC in comparison with other liver tumors.